operating performance. Revenue from Sales for Q2/2022 and Q2/2021 was 6 3 1 .5 3 million baht and 6 5 4 .3 8 million baht, respectively. It decreased 2 2 .8 5 million baht or 3 .4 9 % when compared with Q2
Analysis (MD&A) 2019 Page 3/8 profit equal to 67 million Baht. It was due to a result of the strict credit control by the Company, causing an increase in revenue from collecting (Bad Debt Recovery
months ended 31st December 2019 of the Company and its subsidiaries as details below: (Unit: Baht millions) 1. Operating Performance For the period of three months ended 31st Dec 2019, the net profit for
, increased in compared with administrative expenses of 3.48 percent of total revenue in the same period of the previous year. 1.6 Earning (loss) before interest and tax and Net Profit (loss) For the year ended
and its subsidiary for Quarter 2 of 2019 ending on 30 June 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for
Revenues and Net Profit Consolidated FS Q1/2019 Q1/2020 Change MB. % MB. % MB. % Revenue from contracts with customers 89.9 16.3% 97.1 12.7% 7.1 7.9% Interest income and dividend income 336.4 60.9% 362.8
toll revenue sharing based on the toll rate under the Ministry of Transport’s Announcement dated August 29, 2003 and the toll rates which the Company entitled to receive under the Agreement, calculated
therefore earned net profit in the year 2019 and 2018 amounting THB 35.3 MB and THB 42.6 MB respectively. The Net profit of the Company equal to 4.4% and 4.9% of total revenue respectively, decrease for
previous year which a net loss of Baht 6.39 million, the loss increase Baht 3.6 million or increase by 56.34% , the main reasons are as follow 1. Revenue from sale , Other income The company had revenue from
17.04 million or 10.44% and for nine-month period, the total revenue increases in the amount of Baht 141.04 million or 33.05%. Total Comprehensive Profit and Loss The Company and subsidiary have the total